Earlier today, The Oncology Institute announced that it entered into a business combination agreement with DFP Healthcare Acquisition Corp., which is a publicly traded special purpose acquisition company (SPAC). Upon the closing of this transaction, TOI will be listed as a public company under the ticker TOI on NASDAQ.
The Oncology Institute is leading the shift to value-based oncology care by utilizing a highly scalable and replicable operating model to disrupt the $200 billion U.S. oncology market. Believing that every patient deserves access to world-class care close to home, The Oncology Institute currently manages over 50 community-based practice locations in California, Nevada, Arizona, and Florida. TOI serves approximately 1.3 million lives under value-based contracts and treats over 46,000 patients each year through relationships with leading payors and at-risk physician groups.
The Oncology Institute’s CEO, Brad Hively, stated, “we are committed to applying the principles of value-based care to simultaneously enhance quality and manage costs. For more than 14 years, The Oncology Institute has played a significant role in the lives of cancer patients by providing accessible, high-quality medical care. Our proposed combination with DFP brings us significantly closer to expanding our presence across the United States and advancing our efforts to rebuild the nation’s healthcare system.”
To read the complete press release, click here.
